Please use this identifier to cite or link to this item:
http://publications.jrc.ec.europa.eu/repository/handle/JRC35134| Title: | Control of Prostate Cancer Spheroid Growth Using (213)Bi-labeled Multiple Targeted Alpha Radioimmunoconjugates |
| Authors: | WANG J.; RIZVI S.m.a.; MADIGAN C.; COZZI P.j.; POWER C.a.; QU C.f.; MORGENSTERN ALFRED; APOSTOLIDIS CHRISTOS; RUSSEL P.j.; ALLEN B.j.; LI Y. |
| Citation: | PROSTATE vol. 66 no. 16 p. 1753-1757 |
| Publisher: | WILEY-LISS, INC |
| Publication Year: | 2006 |
| JRC N°: | JRC35134 |
| URI: | http://publications.jrc.ec.europa.eu/repository/handle/JRC35134 |
| Type: | Articles in periodicals and books |
| Abstract: | Micrometastasis is a major problem for prostate cancer CaP patients. Our study investigated the therapeutic potential of multiple targeted alpha-therapy (MTAT) in the treatment pf CaP micrometastases (spheroids) using 213Bi-labeled multiple targeted radioimmunoconjugates. |
| JRC Directorate: | Nuclear Safety and Security |
Files in This Item:
There are no files associated with this item.
Items in repository are protected by copyright, with all rights reserved, unless otherwise indicated.